Glaukos Corporation
COMPOUNDS FOR THE TREATMENT OF OCULAR DISEASE
Last updated:
Abstract:
Disclosed herein are compounds for the treatment of ocular diseases and the preparation and use thereof. Some implementations relate to amine and sulfonamide derivatives and their use as therapeutic agents for the treatment of glaucoma.
Status:
Application
Type:
Utility
Filling date:
21 Feb 2020
Issue date:
21 Apr 2022